FLXN

COM:FLEXIONTHERAPEUTICS

Flexion Therapeutics

  • Stock

USD

Last Close

9.12

01/01 00:00

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
net income
-18.19M
-
-27.31M
50.18%
-46.32M
69.57%
-71.89M
55.23%
-137.48M
91.23%
-169.66M
23.41%
-149.77M
11.72%
-113.71M
24.08%
depreciation and amortization
79.81K
-
120.34K
50.79%
238.15K
97.90%
1.15M
383.29%
2.01M
74.46%
1.71M
14.64%
2.40M
39.79%
3.34M
39.48%
deferred income tax
stock based compensation
996.17K
-
2.45M
146.00%
4.58M
87.00%
6.77M
47.73%
11.54M
70.49%
15.46M
33.94%
15.90M
2.86%
18.58M
16.83%
change in working capital
695.39K
-
1.22M
74.74%
1.48M
22.10%
-1.00M
167.70%
11.80M
1,274.50%
-14.20M
220.39%
-25.54M
79.82%
8.83M
134.57%
accounts receivables
95.28K
-
-410K
530.29%
-12.71M
3,000.24%
-23.99M
88.77%
7.09M
129.55%
inventory
2.77M
-
-1.80M
165.04%
-5.24M
191.50%
-7.67M
46.34%
-922K
87.99%
accounts payables
475.82K
-
518.03K
8.87%
1.58M
205.23%
-992.74K
162.79%
4.19M
521.86%
5.14M
22.76%
1.70M
66.89%
-6.56M
485.43%
other working capital
219.57K
-
697.06K
217.47%
-97.48K
113.98%
-2.87M
2,847.29%
9.82M
441.77%
-1.39M
114.16%
4.42M
418.35%
9.22M
108.41%
other non cash items
228.42K
-
382.73K
67.56%
1.06M
177.56%
2.51M
135.90%
4.30M
71.67%
6.27M
45.77%
8.26M
31.70%
12.40M
50.09%
net cash provided by operating activities
-16.19M
-
-23.14M
42.99%
-38.95M
68.28%
-62.47M
60.40%
-107.83M
72.61%
-160.42M
48.77%
-148.76M
7.27%
-70.56M
52.57%
investments in property plant and equipment
-405.31K
-
-802.48K
97.99%
-5.20M
547.66%
-8.44M
62.38%
-2.15M
74.57%
-852K
60.30%
-3.89M
357.04%
-10.07M
158.58%
acquisitions net
purchases of investments
-15.02M
-
-79.38M
428.67%
-145.80M
83.66%
-196.06M
34.47%
-356.75M
81.96%
-222.48M
37.64%
-115.47M
48.10%
-79.62M
31.05%
sales maturities of investments
31.16M
-
30.73M
1.36%
137.70M
348.03%
72.15M
47.61%
240.23M
232.97%
348.92M
45.24%
234.12M
32.90%
66.90M
71.43%
other investing activites
-98K
-
48K
-
-400K
933.33%
-120K
70%
25K
-
net cash used for investing activites
15.64M
-
-49.45M
416.16%
-13.24M
73.22%
-132.75M
902.31%
-118.79M
10.52%
125.58M
205.72%
114.76M
8.62%
-22.76M
119.83%
debt repayment
-1.50M
-
-3.50M
133.33%
-8.33M
-
-10M
20.00%
-14.37M
43.67%
-15M
4.41%
common stock issued
162.14M
-
147.89M
-
132.67M
10.29%
97.29M
-
common stock repurchased
dividends paid
other financing activites
3.90M
-
-1.13M
129.04%
15.54M
1,472.35%
15.31M
1.50%
199.16M
1,201.12%
3.67M
98.15%
43.38M
1,080.54%
36.49M
15.90%
net cash used provided by financing activities
3.90M
-
159.51M
3,991.09%
12.04M
92.45%
163.20M
1,255.46%
323.50M
98.23%
-6.33M
101.96%
29.02M
558.78%
118.78M
309.31%
effect of forex changes on cash
net change in cash
3.35M
-
86.91M
2,492.04%
-40.15M
146.20%
-32.03M
20.23%
96.87M
402.46%
-41.16M
142.49%
-4.98M
87.91%
25.45M
611.48%
cash at beginning of period
12.84M
-
16.19M
26.12%
103.10M
536.87%
62.94M
38.95%
30.91M
50.88%
128.39M
315.30%
87.23M
32.06%
82.25M
5.70%
cash at end of period
16.19M
-
103.10M
536.87%
62.94M
38.95%
30.92M
50.88%
127.79M
313.35%
87.23M
31.74%
82.25M
5.70%
107.70M
30.94%
operating cash flow
-16.19M
-
-23.14M
42.99%
-38.95M
68.28%
-62.47M
60.40%
-107.83M
72.61%
-160.42M
48.77%
-148.76M
7.27%
-70.56M
52.57%
capital expenditure
-405.31K
-
-802.48K
97.99%
-5.20M
547.66%
-8.44M
62.38%
-2.15M
74.57%
-852K
60.30%
-3.89M
357.04%
-10.07M
158.58%
free cash flow
-16.59M
-
-23.95M
44.33%
-44.15M
84.35%
-70.91M
60.63%
-109.98M
55.09%
-161.27M
46.64%
-152.65M
5.34%
-80.63M
47.18%

All numbers in USD (except ratios and percentages)